Astex Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Astex Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Astex Pharmaceuticals Inc Strategy Report
- Understand Astex Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Astex Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Astex Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Harren Jhoti
President - Astex Pharmaceuticals UK; Chief Executive Officer - Astex Pharmaceuticals UK Executive BoardMr. Harren Jothi has been the Chief Executive Officer and president of the company. Prior to this he served as the Chief Scientific Officer and co-founded Astex in 1999. Prior to this, he worked on the board of the UK BioIndustry Association (BIA) and currently consults for life science venture capital firms.
Harold N. Keer
Chief Medical Officer Senior ManagementMr. Harold N. Keer has been the Chief Medical Officer of the company since 2020. Previously, Dr. Keer served as Vice President, Clinical Development at Five Prime Therapeutics from 2008 to 2013. He also served in multiple roles at Exelixis from 2002 to 2008. He has more than 20 years of drug development experience in industry and academia.
Nipun Davar
Chief Corporate Officer Senior ManagementMr. Nipun Davar has been the Chief Corporate Officer of the company since 2022. Prior to this, he served as the Vice President of Pharmaceutical Development and Manufacturing from 2016 to 2022. Previously, he served as a Corporate Officer and Senior Vice President at Threshold Pharmaceuticals from 2006 to 2011. Mr. Davar, held various leadership positions at ALZA from 1996 to 2006.
David Rees
Chief Scientific Officer - UK Senior ManagementMr. David Rees is been the Chief Scientific Officer of the company. Prior to this, he worked as a medicinal chemist at Organon and AstraZenec, Parke-Davis, Sweden as head of the Medicinal Chemistry Department.
Martin Buckland
President Executive BoardStill looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer